Bender Bruce G, Long Aidan, Parasuraman Bhash, Tran Zung Vu
Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado, USA.
Ann Allergy Asthma Immunol. 2007 Apr;98(4):322-8. doi: 10.1016/S1081-1206(10)60877-0.
Patient nonadherence with asthma controller medication is pervasive and impedes successful adoption of national treatment guidelines.
To survey adult patients with asthma about the factors influencing their decisions about when to use their asthma controller medications.
Two hundred adults with asthma were randomly selected from a national database and were surveyed by telephone about medication use, barriers to adherence, and treatment preferences.
Adherence to daily controller medication in the group was generally well below the prescribed level despite the fact that many had relatively severe asthma and inadequately controlled symptoms. Thirty percent of the respondents indicated that they had been instructed by their physician to use their controller medication intermittently as guided by their symptoms. Most respondents expressed a desire to be more in control of their treatment and for that treatment to be more immediately effective and long-lasting but did not perceive inadequate information to be a barrier to adherence.
These insights into patient perception and motivation suggest the importance of developing treatment plans that allow patients some degree of control over medication use.
患者不坚持使用哮喘控制药物的情况普遍存在，阻碍了国家治疗指南的成功采用。
调查成年哮喘患者在决定何时使用哮喘控制药物时的影响因素。
从一个全国性数据库中随机选取200名成年哮喘患者，通过电话调查其用药情况、依从性障碍和治疗偏好。
尽管许多患者患有相对严重的哮喘且症状控制不佳，但该组患者对每日控制药物的依从性普遍远低于规定水平。30%的受访者表示，医生曾指导他们根据症状间歇性使用控制药物。大多数受访者表示希望对自己的治疗有更多掌控，且治疗能更迅速有效且持久，但并不认为信息不足是依从性的障碍。
这些对患者认知和动机的洞察表明，制定能让患者在一定程度上控制用药的治疗计划非常重要。
